0
We're unable to sign you in at this time. Please try again in a few minutes.
Retry
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
Retry
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
ARTICLE |

THE RELATION OF THROMBOCYTES TO HEMORRHAGIC DIATHESIS

I. W. HELD, M.D.
Arch Intern Med (Chic). 1926;37(3):414-430. doi:10.1001/archinte.1926.00120210119008.
Text Size: A A A
Published online

The clinical study of thrombocytes is rapidly gaining recognition not only in diseases connected with the hematopoietic system but also in infectious and metabolic disorders. Stahl1 and others have recently pointed out the importance that the number, the size and the staining of the thrombocytes play in the diagnosis and prognosis of various diseases. This discussion will be confined chiefly to the rôle played by the thrombocytes in hemorrhagic diathesis.

For a long time the thrombocytes had been considered as imperfect or deformed red cells, that is, the débris of red blood cells. In 1877 Hayem described thrombocytes under the name of hematoblasts because he believed these structures to be youthful forms of red blood cells. In 1881 Brohm observed two cases of Werlhoff's disease and was the first to point out that in this affection the hematoblasts were markedly diminished.

In 1883 Krauss,2 in the clinic of Brohm in

Topics

Sign in

Create a free personal account to sign up for alerts, share articles, and more.

Purchase Options

• Buy this article
• Subscribe to the journal

First Page Preview

View Large
First page PDF preview

Figures

Tables

References

Correspondence

CME
Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.
Submit a Comment

Multimedia

Some tools below are only available to our subscribers or users with an online account.

Sign in

Create a free personal account to sign up for alerts, share articles, and more.

Purchase Options

• Buy this article
• Subscribe to the journal

Related Content

Customize your page view by dragging & repositioning the boxes below.

Jobs
brightcove.createExperiences();